Pages that link to "Q37687351"
Jump to navigation
Jump to search
The following pages link to A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment (Q37687351):
Displaying 7 items.
- MicroRNAs in cancer metastasis and angiogenesis (Q47703386) (← links)
- A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways (Q47903127) (← links)
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release (Q64092533) (← links)
- Quantification of EGFR family in canine mammary ductal carcinomas in situ: implications on the histological graduation (Q90291834) (← links)
- Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo (Q92317311) (← links)
- Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-β1/ZEB1/miR-200c signaling pathway (Q92890258) (← links)
- Ursolic acid inhibits the invasiveness of A498 cells via NLRP3 inflammasome activation (Q99551796) (← links)